AI Analysis
AI-generated analysis. Always verify with the original filing.
FY2025 delivered positive net income for NewGenIvf Group, offsetting steep core operating declines and a significantly widened annual operating loss.
Key Takeaways
1Revenue fell 13% YoY to $4.7M for FY2025, driven by persistently weak domestic demand linked to the prolonged property sector downturn.
2Gross profit declined 47.7% YoY to $955.8K, with full-year gross margin contracting to 20.2% amid elevated service cost pressures.
3Operating loss widened 824% YoY to -$10.7M, as investments in business growth incurred higher-than-anticipated operating expenses.
4Net income reached $9.9M for FY2025, a 1983.1% YoY improvement from the $524.6K net loss recorded in FY2024.
5Diluted EPS came in at $3.04 for FY2025, up from -$0.64 per share in the prior fiscal year, representing a 575.0% YoY increase.
6Management forecasts ongoing cost increases in future periods, which threaten long-term profitability if revenue growth fails to match rising expense levels.